All Curated Mutation Sites in SARS-CoV-2

Back to Mutation Home

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in SARS-CoV-2 related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Furin cleavage site

Methyltransferase

Non-coding region

Keyword: COVID-19-37243279

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	37243279	L302S	RdRp	ORF1b	COVID-19	G R S C L	View
2	37243279	A85S	NSP14	ORF1b	COVID-19	G R S C L	View
3	37243279	N679K	S	S	COVID-19	G R S C L	View
4	37243279	T428I	PLpro	ORF1a	COVID-19	G R S C L	View
5	37243279	D215G	S	S	COVID-19	G R S C L	View
6	37243279	E484K	S	S	COVID-19	G R S C L	View
7	37243279	H655Y	S	S	COVID-19	G R S C L	View
8	37243279	L585F	S	S	COVID-19	G R S C L	View
9	37243279	N501Y	S	S	COVID-19	G R S C L	View
10	37243279	P25L	S	S	COVID-19	G R S C L	View
11	37243279	P9L	S	S	COVID-19	G R S C L	View
12	37243279	R190S	S	S	COVID-19	G R S C L	View
13	37243279	T716I	S	S	COVID-19	G R S C L	View
14	37243279	T859N	S	S	COVID-19	G R S C L	View
15	37243279	Y449H	S	S	COVID-19	G R S C L	View
16	37243279	T819I	PLpro	ORF1a	COVID-19	G R S C L	View
17	37243279	L275F	ORF3a	ORF3a	COVID-19	G R S C L	View
18	37243279	S216L	ORF3a	ORF3a	COVID-19	G R S C L	View
19	37243279	T229N	ORF3a	ORF3a	COVID-19	G R S C L	View
20	37243279	L438P	NSP4	ORF1a	COVID-19	G R S C L	View
21	37243279	E102K	NSP1	ORF1a	COVID-19	G R S C L	View
22	37243279	P13L	N	N	COVID-19	G R S C L	View
23	37243279	I82T	M	M	COVID-19	G R S C L	View
24	37243279	L29F	M	M	COVID-19	G R S C L	View
25	37243279	L21I	E	E	COVID-19	G R S C L	View
26	37243279	S68F	E	E	COVID-19	G R S C L	View
27	37243279	S68P	E	E	COVID-19	G R S C L	View
28	37243279	T24I	3CLpro	ORF1a	COVID-19	G R S C L	View
29	37243279	Q384H	N	N	COVID-19	G R S C L	View
30	37243279	G15S	3CLpro	ORF1a	COVID-19	G R S C L	View
31	37243279	P323L	RdRp	ORF1b	COVID-19	G R S C L	View
32	37243279	D614G	S	S	COVID-19	G R S C L	View
33	37243279	G204R	N	N	COVID-19	G R S C L	View
34	37243279	Y138H	NSP8	ORF1a	COVID-19	G R S C L	View
35	37243279	R203K	N	N	COVID-19	G R S C L	View
36	37243279	T1639A	PLpro	ORF1a	COVID-19	G R S C L	View
37	37243279	H210R	M	M	COVID-19	G R S C L	View
38	37243279	S212R	M	M	COVID-19	G R S C L	View
39	37243279	G204K	N	N	COVID-19	G R S C L	View
40	37243279	R126S	ORF3a	ORF3a	COVID-19	G R S C L	View
41	37243279	H208Y	NSP2	ORF1a	COVID-19	G R S C L	View
42	37243279	C136F	S	S	COVID-19	G R S C L	View
43	37243279	144delY	S	S	COVID-19	G R S C L	View
44	37243279	G671I	RdRp	ORF1b	COVID-19	G R S C L	View

Contents
Description

The table shows all curated mutation sites of SARS-CoV-2 in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.